386 related articles for article (PubMed ID: 33532887)
1. STING-Mediated Lung Inflammation and Beyond.
Frémond ML; Crow YJ
J Clin Immunol; 2021 Apr; 41(3):501-514. PubMed ID: 33532887
[TBL] [Abstract][Full Text] [Related]
2. Lung Inflammation in STING-Associated Vasculopathy with Onset in Infancy (SAVI).
David C; Frémond ML
Cells; 2022 Jan; 11(3):. PubMed ID: 35159128
[TBL] [Abstract][Full Text] [Related]
3. Mutations in COPA lead to abnormal trafficking of STING to the Golgi and interferon signaling.
Lepelley A; Martin-Niclós MJ; Le Bihan M; Marsh JA; Uggenti C; Rice GI; Bondet V; Duffy D; Hertzog J; Rehwinkel J; Amselem S; Boulisfane-El Khalifi S; Brennan M; Carter E; Chatenoud L; Chhun S; Coulomb l'Hermine A; Depp M; Legendre M; Mackenzie KJ; Marey J; McDougall C; McKenzie KJ; Molina TJ; Neven B; Seabra L; Thumerelle C; Wislez M; Nathan N; Manel N; Crow YJ; Frémond ML
J Exp Med; 2020 Nov; 217(11):. PubMed ID: 32725128
[TBL] [Abstract][Full Text] [Related]
4. A defect in COPI-mediated transport of STING causes immune dysregulation in COPA syndrome.
Deng Z; Chong Z; Law CS; Mukai K; Ho FO; Martinu T; Backes BJ; Eckalbar WL; Taguchi T; Shum AK
J Exp Med; 2020 Nov; 217(11):. PubMed ID: 32725126
[TBL] [Abstract][Full Text] [Related]
5. STING Operation at the ER/Golgi Interface.
Taguchi T; Mukai K; Takaya E; Shindo R
Front Immunol; 2021; 12():646304. PubMed ID: 34012437
[TBL] [Abstract][Full Text] [Related]
6. A Human Gain-of-Function STING Mutation Causes Immunodeficiency and Gammaherpesvirus-Induced Pulmonary Fibrosis in Mice.
Bennion BG; Ingle H; Ai TL; Miner CA; Platt DJ; Smith AM; Baldridge MT; Miner JJ
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463976
[TBL] [Abstract][Full Text] [Related]
7. COPA syndrome, 5 years after: Where are we?
Frémond ML; Nathan N
Joint Bone Spine; 2021 Mar; 88(2):105070. PubMed ID: 32919065
[TBL] [Abstract][Full Text] [Related]
8. Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients.
Frémond ML; Hadchouel A; Berteloot L; Melki I; Bresson V; Barnabei L; Jeremiah N; Belot A; Bondet V; Brocq O; Chan D; Dagher R; Dubus JC; Duffy D; Feuillet-Soummer S; Fusaro M; Gattorno M; Insalaco A; Jeziorski E; Kitabayashi N; Lopez-Corbeto M; Mazingue F; Morren MA; Rice GI; Rivière JG; Seabra L; Sirvente J; Soler-Palacin P; Stremler-Le Bel N; Thouvenin G; Thumerelle C; Van Aerde E; Volpi S; Willcocks S; Wouters C; Breton S; Molina T; Bader-Meunier B; Moshous D; Fischer A; Blanche S; Rieux-Laucat F; Crow YJ; Neven B
J Allergy Clin Immunol Pract; 2021 Feb; 9(2):803-818.e11. PubMed ID: 33217613
[TBL] [Abstract][Full Text] [Related]
9. Homeostatic regulation of STING by retrograde membrane traffic to the ER.
Mukai K; Ogawa E; Uematsu R; Kuchitsu Y; Kiku F; Uemura T; Waguri S; Suzuki T; Dohmae N; Arai H; Shum AK; Taguchi T
Nat Commun; 2021 Jan; 12(1):61. PubMed ID: 33397928
[TBL] [Abstract][Full Text] [Related]
10. COPA mutations impair ER-Golgi transport and cause hereditary autoimmune-mediated lung disease and arthritis.
Watkin LB; Jessen B; Wiszniewski W; Vece TJ; Jan M; Sha Y; Thamsen M; Santos-Cortez RL; Lee K; Gambin T; Forbes LR; Law CS; Stray-Pedersen A; Cheng MH; Mace EM; Anderson MS; Liu D; Tang LF; Nicholas SK; Nahmod K; Makedonas G; Canter DL; Kwok PY; Hicks J; Jones KD; Penney S; Jhangiani SN; Rosenblum MD; Dell SD; Waterfield MR; Papa FR; Muzny DM; Zaitlen N; Leal SM; Gonzaga-Jauregui C; ; Boerwinkle E; Eissa NT; Gibbs RA; Lupski JR; Orange JS; Shum AK
Nat Genet; 2015 Jun; 47(6):654-60. PubMed ID: 25894502
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic spectrum in recessive STING-associated vasculopathy with onset in infancy: Four novel cases and analysis of previously reported cases.
Wan R; Fänder J; Zakaraia I; Lee-Kirsch MA; Wolf C; Lucas N; Olfe LI; Hendrich C; Jonigk D; Holzinger D; Steindor M; Schmidt G; Davenport C; Klemann C; Schwerk N; Griese M; Schlegelberger B; Stehling F; Happle C; Auber B; Steinemann D; Wetzke M; von Hardenberg S
Front Immunol; 2022; 13():1029423. PubMed ID: 36275728
[TBL] [Abstract][Full Text] [Related]
12. Heterozygous mutations in the C-terminal domain of COPA underlie a complex autoinflammatory syndrome.
Delafontaine S; Iannuzzo A; Bigley TM; Mylemans B; Rana R; Baatsen P; Poli MC; Rymen D; Jansen K; Mekahli D; Casteels I; Cassiman C; Demaerel P; Lepelley A; Frémond ML; Schrijvers R; Bossuyt X; Vints K; Huybrechts W; Tacine R; Willekens K; Corveleyn A; Boeckx B; Baggio M; Ehlers L; Munck S; Lambrechts D; Voet A; Moens L; Bucciol G; Cooper MA; Davis CM; Delon J; Meyts I
J Clin Invest; 2024 Jan; 134(4):. PubMed ID: 38175705
[TBL] [Abstract][Full Text] [Related]
13. Case Report: Novel SAVI-Causing Variants in
Lin B; Torreggiani S; Kahle D; Rumsey DG; Wright BL; Montes-Cano MA; Silveira LF; Alehashemi S; Mitchell J; Aue AG; Ji Z; Jin T; de Jesus AA; Goldbach-Mansky R
Front Immunol; 2021; 12():636225. PubMed ID: 33833757
[TBL] [Abstract][Full Text] [Related]
14. STING palmitoylation as a therapeutic target.
Hansen AL; Mukai K; Schopfer FJ; Taguchi T; Holm CK
Cell Mol Immunol; 2019 Mar; 16(3):236-241. PubMed ID: 30796349
[TBL] [Abstract][Full Text] [Related]
15. Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling.
Melki I; Rose Y; Uggenti C; Van Eyck L; Frémond ML; Kitabayashi N; Rice GI; Jenkinson EM; Boulai A; Jeremiah N; Gattorno M; Volpi S; Sacco O; Terheggen-Lagro SWJ; Tiddens HAWM; Meyts I; Morren MA; De Haes P; Wouters C; Legius E; Corveleyn A; Rieux-Laucat F; Bodemer C; Callebaut I; Rodero MP; Crow YJ
J Allergy Clin Immunol; 2017 Aug; 140(2):543-552.e5. PubMed ID: 28087229
[TBL] [Abstract][Full Text] [Related]
16. Radioresistant cells initiate lymphocyte-dependent lung inflammation and IFNγ-dependent mortality in STING gain-of-function mice.
Gao KM; Motwani M; Tedder T; Marshak-Rothstein A; Fitzgerald KA
Proc Natl Acad Sci U S A; 2022 Jun; 119(25):e2202327119. PubMed ID: 35696583
[TBL] [Abstract][Full Text] [Related]
17. Novel TMEM173 Mutation and the Role of Disease Modifying Alleles.
Keskitalo S; Haapaniemi E; Einarsdottir E; Rajamäki K; Heikkilä H; Ilander M; Pöyhönen M; Morgunova E; Hokynar K; Lagström S; Kivirikko S; Mustjoki S; Eklund K; Saarela J; Kere J; Seppänen MRJ; Ranki A; Hannula-Jouppi K; Varjosalo M
Front Immunol; 2019; 10():2770. PubMed ID: 31866997
[TBL] [Abstract][Full Text] [Related]
18. STING-associated vasculopathy with onset in infancy (SAVI) presenting with skin lesions.
Latour-Álvarez I; Murcia-Clemente L; Vázquez-Pigueras I; Garramone-Ramírez JE; Clemente D; Sanz V; Torrelo A
Pediatr Dermatol; 2024 Apr; ():. PubMed ID: 38682895
[TBL] [Abstract][Full Text] [Related]
19. The binding of TBK1 to STING requires exocytic membrane traffic from the ER.
Ogawa E; Mukai K; Saito K; Arai H; Taguchi T
Biochem Biophys Res Commun; 2018 Sep; 503(1):138-145. PubMed ID: 29870684
[TBL] [Abstract][Full Text] [Related]
20. A STING antagonist modulating the interaction with STIM1 blocks ER-to-Golgi trafficking and inhibits lupus pathology.
Prabakaran T; Troldborg A; Kumpunya S; Alee I; Marinković E; Windross SJ; Nandakumar R; Narita R; Zhang BC; Carstensen M; Vejvisithsakul P; Marqvorsen MHS; Iversen MB; Holm CK; Østergaard LJ; Pedersen FS; Pisitkun T; Behrendt R; Pisitkun P; Paludan SR
EBioMedicine; 2021 Apr; 66():103314. PubMed ID: 33813142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
